Suven Pharmaceuticals Ltd Share Price
(SUVENPHAR)
Check the latest share price of Suven Pharmaceuticals Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 12 May 2025
NSE
Suven Pharmaceuticals Ltd Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹1,041.6Day's Price Range₹1,09852 Week's Low
52 Week's High
₹59852-Week Price Range₹1,360
| Returns % | |
| 1 Month Return | -10.25 % |
| 3 Month Return | -5.07 % |
| 1 Year Return | + 60.38 % |
| 3 Year Return | + 103.85 % |
| 5 Year Return | + 549.62 % |
| Market Stats | |
| Previous Close | ₹1,077.80 |
| Open | ₹1,077.80 |
| Volume | 2.37L |
| Upper Circuit | ₹1,293.30 |
| Lower Circuit | ₹862.30 |
Suven Pharmaceuticals Ltd Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹27,067.89 Cr
Return on Equity (ROE)
14.31
PE Ratio (TTM)
96.84
Return on capital employed (ROCE)
18.82
Industry PE ratio
53.64
Beta (LTM)
0.56
P/B Ratio
8.38
Dividend Yield
0PEG Ratio
-26.9
Quarterly Earnings Growth YOY
78.16
EPS (TTM)
11.8
Sector
Pharmaceuticals
Book Value
80.56
Technical Analysis
Bearish
View Technical Analysis
How to invest in Suven Pharmaceuticals Ltd
Investing in Suven Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Suven Pharmaceuticals Ltd or SUVENPHAR on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Suven Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Suven Pharmaceuticals Ltd with just a few clicks!
Suven Pharmaceuticals Ltd Stock's Interest Amongst Investors
Suven Pharmaceuticals Ltd Valuation
Track how the P/E of Suven Pharmaceuticals Ltd has moved over time to understand valuation trends.
Suven Pharmaceuticals Ltd in the last 5 years
Lowest (4.48x)
March 30, 2020
Industry (53.64x)
May 12, 2025
Today (96.84x)
May 12, 2025
Highest (139.56x)
November 5, 2024
Today’s Price to Earnings Ratio: 96.84x
Analysts Recommendation on Suven Pharmaceuticals Ltd
Get updated buy, sell, and hold recommendations by analysts on Suven Pharmaceuticals Ltd.
based on 6 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Suven Pharmaceuticals Ltd. Average target price of ₹1396.67
Source: S&P Global Market Intelligence
Analysts Forecast on Suven Pharmaceuticals Ltd
Get share price movements and forecasts by analysts on Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd price forecast by 6 analysts
Upside of31.35%
High
₹1500
Target
₹1396.67
Low
₹1290
Suven Pharmaceuticals Ltd target price ₹1396.67, a slight upside of 31.35% compared to current price of ₹1063.3. According to 6 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Suven Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:292.25%
Forecast
Actual
Including amortisation and stock based compensations
Suven Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:114.92%
Forecast
Actual
Source: S&P Global Market Intelligence
Suven Pharmaceuticals Ltd Financials
Get the annual and quarterly financial summary of Suven Pharmaceuticals Ltd, including revenue, profit, loss and more.
Suven Pharmaceuticals Ltd Index Inclusions
Suven Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd Earnings Results
Suven Pharmaceuticals Ltd’s net profit jumped 77.28% since last year same period to ₹82.88Cr in the Q3 2024-2025. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated 0.81% jump in its net profits since last 3-months.
Read More about Earnings ResultsSuven Pharmaceuticals Ltd Dividends September,2022
In the quarter ending June 2022, Suven Pharmaceuticals Ltd has declared dividend of ₹1 - translating a dividend yield of 1.03%.
Read More about Dividends
Suven Pharmaceuticals Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Suven Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.1% | 0.00 | |
| Foreign Institutions | 11.05% | 0.00 | |
| Mutual Funds | 13.04% | 0.00 | |
| Retail Investors | 22.23% | 0.00 | |
| Others | 3.58% | 0.00 |
Suven Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Suven Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 27,067.89 | 109.92% | 0.52 | 300 | 1,051 | |
| BUY | 14,004.86 | 27.28% | 0.57 | 72 | 6,702 | |
| NA | 4,823.36 | 2.39% | 0.79 | -388 | 75 | |
| BUY | 13,733.85 | 40.08% | 0.68 | 218 | 1,296 | |
| HOLD | 25,140.94 | 159.21% | 0.55 | 258 | 1,375 |
Suven Pharmaceuticals Ltd News & Key Events
Latest news and events at one place to help you take investing decisions in Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Rebrands to Cohance Lifesciences - 08 May, 2025
Suven Pharmaceuticals has changed its name to Cohance Lifesciences, effective May 7, 2025. This rebranding reflects the company's commitment to innovation in the CDMO sector.Suven Pharmaceuticals Targets $1 Billion Revenue by 2030 - 05 May, 2025
Suven Pharmaceuticals reports increased engagement at industry events, focusing on advanced capabilities like ADCs and peptides. The company aims for $1 billion in revenue by 2030, driven by CDMO momentum.Suven Pharmaceuticals Merger with Cohance Approved - 25 Apr, 2025
The merger between Suven Pharmaceuticals and Cohance Lifesciences will take effect on May 1, 2025, aiming to create a diversified CDMO platform. The National Company Law Tribunal approved the merger on March 27, with plans for aggressive expansion and a revenue target of Rs 6000 crore by FY29.Suven Pharma Advances with Merger and Global Engagement - 23 Apr, 2025
Suven Pharmaceuticals received regulatory approval for increasing foreign investment post-merger with Cohance Lifesciences. The company also sees heightened interest from global pharma firms seeking alternatives to China.
Insights on Suven Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, SUVENPHAR stock has moved up by 62.6%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SUVENPHAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 248.85 Cr → 322.86 Cr (in ₹), with an average increase of 12.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, 46.75 Cr → 82.88 Cr (in ₹), with an average increase of 12.9% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 10.84% to 11.05% in Mar 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 50.10% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 150.9% return, outperforming this stock by 42.0%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 22.37% to 22.23% in Mar 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 13.15% to 13.04% in Mar 2025 quarter
About Suven Pharmaceuticals Ltd
Revenue: ₹307.15Cr as on December 2024 (Q4 24)
Net Profit: ₹83.29Cr as on December 2024 (Q4 24)
Listing date: 05 Mar, 2020
Chairperson Name: Annaswamy Vaidheesh
| Organisation | Suven Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Annaswamy Vaidheesh |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Suven Pharmaceuticals Ltd
Check out the Mutual Funds with significant holdings in Suven Pharmaceuticals Ltd.
FAQs
What is Suven Pharmaceuticals Ltd price today?
Suven Pharmaceuticals Ltd share price today stands at ₹1063.3, Open: ₹1077.8, Previous Close: ₹1077.8, High: ₹1098, Low: ₹1041.6, 52 Week High: ₹1360, 52 Week Low: ₹598.
How to Buy Suven Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Suven Pharmaceuticals Ltd shares
What are today's traded volumes of Suven Pharmaceuticals Ltd?
Today's traded volume of Suven Pharmaceuticals Ltd(SUVENPHAR) is 2.37L.
What is today's market capitalisation of Suven Pharmaceuticals Ltd?
Today's market capitalisation of Suven Pharmaceuticals Ltd(SUVENPHAR) is ₹27,067.89 Cr.
What is the 52 Week High and Low Range of Suven Pharmaceuticals Ltd?
How much percentage Suven Pharmaceuticals Ltd is down from its 52 Week High?
Suven Pharmaceuticals Ltd (SUVENPHAR) share price is ₹1063.3. It is down -21.82% from its 52 Week High price of ₹1360
How much percentage Suven Pharmaceuticals Ltd is up from its 52 Week low?
Suven Pharmaceuticals Ltd (SUVENPHAR) share price is ₹1063.3. It is up 77.81% from its 52 Week Low price of ₹598